Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 6/20 | 0.49 |
| ▸ | L3MBTL1 | Q9Y468 | 5/20 | 0.49 |
| ▸ | NPSR1 | Q6W5P4 | 4/20 | 0.49 |
| ▸ | ATM | Q13315 | 3/20 | 0.47 |
| ▸ | MAPK1 | P28482 | 4/20 | 0.45 |
| ▸ | LMNA | P02545 | 2/20 | 0.45 |
| ▸ | POLB | P06746 | 2/20 | 0.45 |
| ▸ | USP2 | O75604 | 1/20 | 0.45 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.45 |
| ▸ | GFER | P55789 | 1/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.43 |
| ▸ | MEN1 | O00255 | 3/20 | 0.43 |
| ▸ | TSHR | P16473 | 1/20 | 0.43 |
| ▸ | GAA | P10253 | 3/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.41 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.41 |
| ▸ | KCNQ2 | O43526 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20436324 | 0.89 | ALDH1A1 (0.47) | MAPTL3MBTL1NPSR1MAPK1LMNA | |
| SCHEMBL24200370 | 0.79 | PARP14 (0.44) | MAPTL3MBTL1MAPK1LMNAPOLB | |
| SCHEMBL20436314 | 0.78 | ITGB1 (0.37) | MAPTL3MBTL1NPSR1MAPK1LMNA | |
| SCHEMBL4403976 | 0.78 | ITGB1 (0.55) | MAPTL3MBTL1POLBALDH1A1GAA | |
| SCHEMBL20436316 | 0.76 | GAA (0.38) | MAPTL3MBTL1NPSR1ATMMAPK1 | |
| SCHEMBL20436310 | 0.76 | NLRP3 (0.36) | MAPTL3MBTL1NPSR1MAPK1LMNA | |
| SCHEMBL24200372 | 0.70 | LMNA (0.34) | MAPTL3MBTL1LMNAALDH1A1 | |
| SCHEMBL10030203 | 0.69 | POLB (0.39) | MAPTL3MBTL1LMNAPOLBALDH1A1 | |
| SCHEMBL20458582 | 0.69 | CHRM3 (0.35) | MAPTL3MBTL1LMNAPOLBALDH1A1 | |
| SCHEMBL13763656 | 0.69 | NPSR1 (0.65) | MAPTL3MBTL1NPSR1ATMLMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11327060-B2 | Method for analyzing enantiomer | AJINOMOTO CO., INC. (JP) | 2022-05-10 | — | — | US | disclosed |
| EP-3358346-B1 | ENANTIOMER ANALYSIS METHOD | AJINOMOTO KK (JP) | 2022-01-19 | — | — | EP | disclosed |
| EP-3358346-A1 | ENANTIOMER ANALYSIS METHOD | Ajinomoto Co., Inc. (JP) | 2018-08-08 | — | — | EP | disclosed |
| US-20180217113-A1 | METHOD FOR ANALYZING ENANTIOMER | AJINOMOTO CO., INC. (JP) | 2018-08-02 | — | — | US | disclosed |
| US-20180217113-A1 | METHOD FOR ANALYZING ENANTIOMER | AJINOMOTO CO., INC. (JP) | 2018-08-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11327060-B2 | Method for analyzing enantiomer | DCX, INF2, SRD5A2 | MAPT 3206/4885L3MBTL1 2085/4885NPSR1 3422/4885 |
| US-20180217113-A1 | METHOD FOR ANALYZING ENANTIOMER | DCX, INF2, SRD5A2 | MAPT 3206/4885L3MBTL1 2085/4885NPSR1 3422/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.